 |
市场调查报告书
商品编码
1674336
TCV 疫苗市场按疫苗品牌、通路和地区划分TCV Vaccines Market, By Vaccine Brand (Ty21a (Vivotif), ViCPS (Typhim Vi), Vi-TT (Peda-typhTM), and Typbar TCV), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) |
||||||
2025 年全球 TCV 疫苗市场规模估计为 4.649 亿美元，预计到 2032 年将达到 10.675 亿美元，2025 年至 2032 年的复合年增长率为 12.6%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 4.649亿美元 |
| 效能资料 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025 年至 2032 年复合年增长率 | 12.60％ | 2032 年金额预测 | 10.675亿美元 |
由于疾病和感染疾病率的不断上升，TCV 疫苗市场在过去几年一直稳步增长。 TCV 疫苗针对的是破伤风、白喉和百日咳等高度传染性的细菌性呼吸道疾病。百日咳对婴儿和幼儿尤其危险，这是全球疫苗接种计画的主要动力。破伤风和白喉疫苗接种覆盖率在世界范围内很高，但百日咳仍在学校和社区中蔓延，需要常规接种疫苗。开发中国家对疫苗接种益处的认识不断提高，政府加强常规免疫计画的措施正在增加市场收益。最近的新产品核可和评估扩大适应症的大规模临床试验为该市场提供了进一步的成长机会。
市场动态
由于新兴市场的需求不断增加以及全球疫苗接种计划的扩大，TCV 疫苗市场预计将继续保持强劲成长。推动市场发展的关键因素包括父母意识的不断增强、国际卫生组织对保护弱势群体的建议日益增多以及政府对中低收入国家的补贴和资助。然而，联合疫苗的研究、开发、生产和分发高成本，对疫苗的普及构成了重大挑战。此外，由于错误讯息和宗教信仰而导致的疫苗犹豫正在阻碍一些国家的市场潜力。
研究的主要特点
本报告对全球 TCV 疫苗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球 TCV 疫苗市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数列出的。
主要企业包括 GSK plc.、Sanofi、Bharat BIoTech、BioFarma、Zydus Group、Emergent BioSolutions Inc.、Bavarian Nordic Inc.、Crucell Switzerland LTD.、PaxVax, Inc. 和 BIO-MED。
本报告中的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球 TCV 疫苗市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过全球 TCV 疫苗市场分析中使用的各种策略矩阵更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 监管情景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购情景
- 市场趋势
- 流行病学
4. 2020 年至 2032 年全球 TCV 疫苗市场（依疫苗品牌划分）
- 介绍
- Ty21a (Vivotiv)
- ViCPS (伤寒 Vi)
- Vi-TT (教学法)
- 类型 条形 TCV
5. 2020 年至 2032 年全球 TCV 疫苗市场依通路划分
- 介绍
- 公共
- 联合国儿童基金会
- 竞标（政府）
- 私人的
6. 全球 TCV 疫苗市场，依地区、价值，2020 年至 2032 年
- 介绍
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第七章 竞争格局
- GSK plc.
- Sanofi
- Bharat BIoTech
- BioFarma
- Zydus Group
- Emergent BioSolutions Inc.
- Bavarian Nordic Inc.
- Crucell Switzerland LTD.
- PaxVax, Inc.
- BIO-MED
第 8 章分析师建议
- 兴衰
- 一致的机会地图
第九章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Global Tcv Vaccines Market is estimated to be valued at USD 464.9 Mn in 2025 and is expected to reach USD 1,067.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 464.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 12.60% | 2032 Value Projection: | USD 1,067.5 Mn |
The TCV vaccines market has been witnessing steady growth over the past few years due to increasing incidence of diseases and infections. TCV vaccines target tetanus, diphtheria, and pertussis/whooping cough which are highly infectious bacterial respiratory diseases. Pertussis is especially dangerous for infants and young children which has been a key factor driving vaccination programs globally. While tetanus and diphtheria vaccination rates are high worldwide, pertussis continues to spread in schools and communities necessitating regular booster doses. Growing awareness about benefits of immunization and government efforts to strengthen routine immunization programs in developing countries have boosted market revenues. Recent new product approvals and large clinical trials evaluating expansion of indication have further widened growth opportunities in this market.
Market Dynamics:
TCV vaccines market is expected to witness robust growth going forward on account of rising demand from developing regions and increasing coverage of vaccination programs worldwide. The key drivers fueling the market include growing awareness among parents, expanding recommendation by international health organizations to protect vulnerable population groups, and government subsidies and funding in low and middle income nations. However, high costs associated with R&D, manufacturing, and distribution of combination vaccines pose a major challenge to adoption rates. In addition, ongoing vaccine hesitancy due to misinformation and religious beliefs inhibits market potential in some countries.
Key Features of the Study:
This report provides in-depth analysis of the global TCV vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global TCV vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK plc., Sanofi, Bharat Biotech, BioFarma, Zydus Group, Emergent BioSolutions Inc., Bavarian Nordic Inc., Crucell Switzerland LTD., PaxVax, Inc., and BIO-MED
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global TCV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global TCV vaccines market
Market Segmentation
- By Vaccine Brand Insights (Revenue, USD Mn, 2020 - 2032)
- Ty21a (Vivotif)
- ViCPS (Typhim Vi)
- Vi-TT (Peda-typhTM)
- Typbar TCV
- By Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Public
- UNICEF
- Tender (Govt.)
- Private
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GSK plc.
- Sanofi
- Bharat Biotech
- BioFarma
- Zydus Group
- Emergent BioSolutions Inc.
- Bavarian Nordic Inc.
- Crucell Switzerland LTD.
- PaxVax, Inc.
- BIO-MED
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- TCV Vaccines Market, By Vaccine Brand
- TCV Vaccines Market, By Distribution Channel
- TCV Vaccines Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Market Trends
- Epidemiology
4. Global TCV Vaccines Market, By Vaccine Brand, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Ty21a (Vivotif)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- ViCPS (Typhim Vi)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Vi-TT (Peda-typhTM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Typbar TCV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global TCV Vaccines Market, By Distribution Channel, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- UNICEF
- Tender (Govt.)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global TCV Vaccines Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
7. Competitive Landscape
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioFarma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bavarian Nordic Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Crucell Switzerland LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PaxVax, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BIO-MED
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
8. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. References and Research Methodology
- References
- Research Methodology
- About us
联合脊髓灰质炎疫苗市场按疫苗类型、接种途径、技术、新兴市场发展阶段和最终用户划分 - 2025-2030 年全球预测
狂犬病疫苗市场报告：趋势、预测和竞争分析（至 2031 年）
预防疫苗市场按疫苗类型、疾病类型、分销管道和地区划分人类狂犬病疫苗市场：按细胞株类型、给药途径、应用、分销管道 - 全球预测 2025-2030
兽用狂犬病疫苗市场、机会、成长动力、产业趋势分析与预测，2024-2032狂犬病疫苗市场 - 按产品类型 [婴儿仓鼠肾 (BHK)、Vero 细胞狂犬病疫苗]、类型（人用、兽用）、应用（暴露前预防、暴露后预防）、配销通路、全球预测（2024 年- 2032 年）狂犬病疫苗市场，按产品类型、应用、预防类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
狂犬病疫苗市场：按产品类型、按预防类型、按应用、按最终用户：2023-2032 年全球机会分析和产业预测百日咳疫苗市场报告：2030 年趋势、预测与竞争分析灭活脊髓灰质炎·狂犬病(恐水症)疫苗市场:疫苗，各灭活方法，各年龄层，各流通管道，各地区- 市场规模，占有率，展望，机会分析，2023年～2030年